NeuroBlu is a real-world data (RWD) platform developed by Holmusk, comprised of de-identified electronic health record (EHR) data from patients receiving mental and behavioural healthcare across more than 30 health systems in the United States of America. Initially containing data on 562,940 patients in 2021, the platform has since expanded significantly and now includes records from over 35 million individuals. The data, retrospectively collected from both inpatient and outpatient settings using systems such as MindLinc, spans more than 20 years (1999–2025) and includes structured and unstructured information on demographics, diagnoses, clinical severity, hospital admissions, prescribed medications, and service use. Natural language processing (NLP) tools are used to extract additional detail from unstructured clinical notes. Patients are not directly recruited but are included through data-sharing agreements with healthcare providers, and new records continue to be added as patients receive ongoing care. Follow-up duration varies by patient, with a median of 7 months, and is dependent on the frequency of clinical encounters recorded in the EHR.

Recruitment is ongoing